This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (27)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

William M. Pardridge, MD

Arch Neurol. 2002;59:35-40.

The blood-brain barrier (BBB) is maintained by the endothelial tight junctions within the brain microvasculature. Most small-molecule neuropharmaceutical agents and virtually all large-molecule drugs do not cross the BBB. The BBB problem is the rate-limiting factor preventing the transfer of progress in the molecular neurosciences to the development of clinically effective neurotherapeutic agents. The future development of neurotherapeutic agents will be accelerated by the development of BBB drug-targeting technology.

From the Department of Medicine, University of California, Los Angeles, UCLA School of Medicine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(1):155-157.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Biotinylation Facilitates the Uptake of Large Peptides by Escherichia coli and Other Gram-Negative Bacteria
Walker and Altman
Appl. Environ. Microbiol. 2005;71:1850-1855.
ABSTRACT | FULL TEXT  

Attenuated Central Nervous System Infection in Advanced HIV/AIDS With Combination Antiretroviral Therapy
McArthur et al.
Arch Neurol 2004;61:1687-1696.
ABSTRACT | FULL TEXT  

Through a Glass, Darkly: Cerebrospinal Fluid Viral Load Measurements and the Pathogenesis of Human Immunodeficiency Virus Infection of the Central Nervous System
Tyler and McArthur
Arch Neurol 2002;59:909-912.
FULL TEXT  

Experimental Neurotherapeutics: Leaps and Bounds
Shoulson
Arch Neurol 2002;59:689-691.
FULL TEXT